Nanophase Technologies Corp
Formerly NANOPHASE TECHNOLOGIES CORPORATION
Nanophase Technologies Corp is listed today as Solesence, Inc.: market value, financials and filings are on its company page.
Funding rounds
0 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Dec 2017 | $1 M | Private placement after listing | Under $2 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
As the listed company Solesence, Inc., its revenue in fiscal 2025 came from these product and service lines: Consumer Products $54.87 million (88%), Personal Care ingredients $6.34 million (10%), Advanced Materials $860,000 (1%), Product and Service, Other $270,000 (0%).
Annual report (SEC XBRL) · Dec 2025
Nanophase Technologies Corp had revenue between $5 million and $25 million when it filed its newest notice of a funding round (Dec 2017).
SEC Form D (revenue range) · Dec 2017
The industry group it chose in its notices: Manufacturing.
SEC Form D · Dec 2017
Products and services#
No products or services of Nanophase Technologies Corp are on record.
Investors#
No investor of Nanophase Technologies Corp is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete.
Largest shareholders today
Institutions holding Solesence, Inc. shares, as of Sep 30, 2026.
- Vanguard Capital Management LLC$1 M1.15%
- BlackRock, Inc.$0 M0.46%
- Bank of New York Mellon Corp$0 M0.45%
- Millennium Management LLC$0 M0.37%
- Geode Capital Management, LLC$0 M0.32%
- Morgan Stanley$0 M0.26%
- Donaldson Capital Management, LLC$0 M0.21%
- Susquehanna International Group, LLP$0 M0.16%
- Vanguard Fiduciary Trust Co$0 M0.15%
- Jane Street Group, LLC$0 M0.09%
- Northern Trust Corp$0 M0.05%
- Zacks Investment Management$0 M0.04%
- Wealth Enhancement Advisory Services, LLC$0 M0.03%
- Barclays PLC$0 M0.03%
- Qube Research & Technologies Ltd$0 M0.02%
Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Jess A. Jankowski | Executive officer | Dec 2017 |
| Kevin A. Cureton | Executive officer | Dec 2017 |
| Nancy A. Baldwin | Executive officer | Dec 2017 |
| George A. Vincent | Director | Dec 2017 |
| James A. Henderson | Director | Dec 2017 |
| James A. McClung | Director | Dec 2017 |
| Jess A. Jankowski | Director | Dec 2017 |
| R. Janet Whitmore | Director | Dec 2017 |
| Richard W. Siegel | Director | Dec 2017 |
| W. Ed Tyler | Director | Dec 2017 |
Went public since 2012. Its SEC number is that of a company listed on a stock exchange.